SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is capturing significant community attention ahead of their upcoming quarterly earnings report, with investors debating whether the company's AI-driven growth and commercial expansion can justify its current valuation. While bulls highlight strong demand for the Artificial Intelligence Platform and consistent beats in previous quarters, bears remain cautious about the stock's premium valuation and the potential for a sell-the-news event following a period of high market anticipation.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is trending after securing final OCC approval to establish a federally regulated national trust bank, a milestone investors view as a key regulatory moat. While the stock initially surged on the news, community sentiment remains split between bullish long-term holders eyeing the company's potential to bridge digital and traditional finance and wary traders focused on aggressive short-selling and pricing pressures from competitors.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors show renewed bullish sentiment ahead of upcoming second-quarter financial results, with the community actively discussing potential catalysts like store expansion, margin improvements, and persistent rumors regarding a future U.S. exchange relisting. Despite ongoing debate over OTC market risks and past corporate governance concerns, many shareholders are highlighting the company's rapid growth and strong operational execution in the Chinese market as reasons for their continued optimism.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is currently a focal point of intense community discussion, driven by the pending finalization of its SkyWater Technology acquisition and anticipation surrounding upcoming quarterly earnings and investor day. Traders are actively debating the company's long-term valuation, technical roadmap for scaling fault-tolerant quantum computing, and the strategic implications of its vertical integration strategy amid broader market volatility.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing increased investor focus due to a combination of strong quarterly performance and strategic pipeline milestones, including recent FDA regulatory progress and new clinical trial collaborations. The community is actively discussing the company's efforts to balance generic headwinds against its growth portfolio, while monitoring potential M&A activity as the firm looks to bolster its late-stage assets.

JinkoSolar Holding Co., Ltd. engages in the manufacture of solar modules. It distributes solar products and sells its solutions and services to a diversified international utility, commercial and residential customers. The company was founded by Xian De Li, Kang Ping Chen, and Xian Hua Li in June 2006 and is headquartered in Shangrao, China.

JinkoSolar Holding Co. Ltd - ADR

JinkoSolar Holding Co LTD

JinkoSolar is trending due to widespread community sentiment that the stock is severely undervalued relative to its high revenue, triple AAA bankability rating, and consistent contract wins. Investors are actively discussing the potential for a short squeeze, citing high short interest against a limited float, while also highlighting the company's expansion in energy storage and global market presence.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing significant investor attention following the EU approval of the Wegovy pill and sustained high demand for its oral GLP-1 treatments, fueling optimism for continued market leadership. The community is closely debating the company's competitive position against Eli Lilly, with many bullish investors highlighting the oral drug's prescription momentum as a primary catalyst for potential upcoming guidance upgrades and price appreciation.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is surging as investors react to a strategic integration of its Qwen AI models into Apple Intelligence in China, providing a major distribution catalyst for its cloud and AI ecosystem. The stock is also gaining momentum from a broader rebound in Chinese equities and ongoing interest in the company's AI infrastructure, which the community is actively tracking for potential technical breakouts.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is drawing attention as investors weigh a strong earnings beat and a significant increase to its share buyback program against concerns over slowing growth rates and industry-wide tariff pressures. While the community remains divided between those viewing the stock as a long-term value play driven by HOKA's brand momentum and others frustrated by its volatile, range-bound performance, the stock continues to be a focal point for institutional portfolio adjustments.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid community frustration over the temporary shelving of the Clarity Act and ongoing debates regarding Ripples monthly escrow activity. Investors remain deeply divided between long-term believers in the network's cross-border utility and critics calling for exits as the price faces continued downward pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INOVIO Announces Pricing of $20.0 Million Public Offering

INOVIO Announces Pricing of $20.0 Million Public Offering INOVIO Announces Pricing of $20.0 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29, 2026 PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on...

INOVIO Announces Proposed Public Offering

INOVIO Announces Proposed Public Offering INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29, 2026 PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA...

Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

INOVIO to Participate in Upcoming Scientific and Investor Conferences

INOVIO to Participate in Upcoming Scientific and Investor Conferences INOVIO to Participate in Upcoming Scientific and Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., May 28, 2026 PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on...

INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial  

Equity

The study showed that the treatment helped reverse precancerous changes in the cervix and clear the high-risk HPV virus that causes them in many patients. 


Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China

Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China PR Newswire...

Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call

INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights

INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING...

MRNA, INO, SABS, NVAX Stocks Jump Premarket: Deadly Hantavirus Reaches US After Cruise Ship Outbreak 

The HHS confirmed that one American passenger evacuated from the MV Hondius cruise ship tested mildly positive for the Andes strain of hantavirus.

INOVIO to Participate in Upcoming Scientific Conferences

INOVIO to Participate in Upcoming Scientific Conferences INOVIO to Participate in Upcoming Scientific Conferences PR Newswire PLYMOUTH MEETING, Pa., May 8, 2026 PLYMOUTH MEETING, Pa., May 8, 2026...

$INO Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.28 up 45.10% YoY
• INOVIO anticipates its cash, cash equivalents, and short-term investments will fund operations into Q1 2027, past the INO-3107 PDUFA date, including $16M from an April 2026 offering and an estimated $18M Q2 2026 cash burn.

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Inovio Pharmaceuticals Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

INOInovio Pharmaceuticals Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest INO News